Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising

Under the Food, Drug, and Cosmetic Act, all promotional materials for prescription drugs must strike a fair balance in presentation of risks and benefits. How to best present this information is not clear. We sought to determine if the presentation of quantitative risk and benefit information in drug advertising and labeling influences consumers’, patients’, and clinicians’ information processing, knowledge, and behavior by assessing available empirical evidence.

[1]  M. Galesic,et al.  Using plausible group sizes to communicate information about medical risks. , 2011, Patient education and counseling.

[2]  D. White,et al.  A randomized trial of two methods to disclose prognosis to surrogate decision makers in intensive care units. , 2010, American journal of respiratory and critical care medicine.

[3]  Yu Yong,et al.  Risk communication in clinical trials: A cognitive experiment and a survey , 2010, BMC Medical Informatics Decis. Mak..

[4]  Angela Fagerlin,et al.  Presenting Research Risks and Benefits to Parents: Does Format Matter? , 2010, Anesthesia and analgesia.

[5]  Sarah M. Greene,et al.  Testing whether decision aids introduce cognitive biases: results of a randomized trial. , 2010, Patient education and counseling.

[6]  B. Zikmund‐Fisher,et al.  The Effect of Format on Parents' Understanding of the Risks and Benefits of Clinical Research: A Comparison Between Text, Tables, and Graphics , 2010, Journal of health communication.

[7]  M. Vahabi.  Verbal versus numerical probabilities: Does format presentation of probabilistic information regarding breast cancer screening affect women’s comprehension? , 2010 .

[8]  B. Zikmund‐Fisher,et al.  Effect of Various Risk/Benefit Trade-offs on Parents’ Understanding of a Pediatric Research Study , 2010, Pediatrics.

[9]  P. Gardner,et al.  Perceived risk of tamoxifen side effects: a study of the use of absolute frequencies or frequency bands, with or without verbal descriptors. , 2010, Patient education and counseling.

[10]  P. Ubel,et al.  A Demonstration of ‘‘Less Can Be More’’ in Risk Graphics , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  M. Galesic,et al.  Who profits from visual aids: overcoming challenges in people's understanding of risks [corrected]. , 2010, Social science & medicine.

[12]  Cheryl L. L. Carling,et al.  The Effect of How Outcomes Are Framed on Decisions about Whether to Take Antihypertensive Medication: A Randomized Trial , 2010, PloS one.

[13]  M. Galesic,et al.  Communicating treatment risk reduction to people with low numeracy skills: a cross-cultural comparison. , 2009, American journal of public health.

[14]  P. Slovic,et al.  The Use of Narrative Evidence and Explicit Likelihood by Decisionmakers Varying in Numeracy , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[15]  Andrew D. Oxman,et al.  The Effect of Alternative Graphical Displays Used to Present the Benefits of Antibiotics for Sore Throat on Decisions about Whether to Seek Treatment: A Randomized Trial , 2009, PLoS medicine.

[16]  Steven Woloshin,et al.  Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials , 2009, Annals of Internal Medicine.

[17]  Vivianne H M Visschers,et al.  Probability Information in Risk Communication: A Review of the Research Literature , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[18]  Marcos Bosi Ferraz,et al.  Development and testing of a decision board to help clinicians present treatment options to lupus nephritis patients in Brazil. , 2008, Arthritis and rheumatism.

[19]  Angela Fagerlin,et al.  Improving understanding of adjuvant therapy options by using simpler risk graphics , 2008, Cancer.

[20]  P. Ubel,et al.  The impact of the format of graphical presentation on health-related knowledge and treatment choices. , 2008, Patient education and counseling.

[21]  Cheryl L. L. Carling,et al.  How Should the Impact of Different Presentations of Treatment Effects on Patient Choice Be Evaluated? A Pilot Randomized Trial , 2008, PloS one.

[22]  P. Ubel,et al.  Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. , 2008, Patient education and counseling.

[23]  Cara L Cuite,et al.  A Test of Numeric Formats for Communicating Risk Probabilities , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[24]  Lisa M. Schwartz,et al.  PSYCHOLOGICAL SCIENCE IN THE PUBLIC INTEREST Helping Doctors and Patients Make Sense of Health Statistics , 2022 .

[25]  Amiram Gafni,et al.  Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. , 2007, Archives of internal medicine.

[26]  Erika A. Waters,et al.  Reducing aversion to side effects in preventive medical treatment decisions. , 2007, Journal of experimental psychology. Applied.

[27]  Glyn Elwyn,et al.  Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial. , 2006, Patient education and counseling.

[28]  Erika A. Waters,et al.  Formats for Improving Risk Communication in Medical Tradeoff Decisions , 2006, Journal of health communication.

[29]  D Feldman-Stewart,et al.  Communicating quality of life information to cancer patients: a study of six presentation formats. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  P. Ubel,et al.  Reducing the Influence of Anecdotal Reasoning on People’s Health Care Decisions: Is a Picture Worth a Thousand Statistics? , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  P. Ravdin,et al.  Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk Information , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[32]  Y. Cheung,et al.  Risk perception is affected by modes of risk presentation among Singaporeans. , 2005, Annals of the Academy of Medicine, Singapore.

[33]  Celia E. Wills,et al.  Bmc Medical Informatics and Decision Making Treatment Decision-making and the Form of Risk Communication: Results of a Factorial Survey , 2004 .

[34]  Jonathan Baron,et al.  Intended Message Versus Message Received in Hypothetical Physician Risk Communications: Exploring the Gap , 2004, Risk analysis : an official publication of the Society for Risk Analysis.

[35]  P. Knapp,et al.  Comparison of two methods of presenting risk information to patients about the side effects of medicines , 2004, Quality and Safety in Health Care.

[36]  Jonathan Baron,et al.  The Effect of Numerical Statements of Risk on Trust and Comfort with Hypothetical Physician Risk Communication , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[37]  Peter Knapp,et al.  Over the counter medicines and the need for immediate action: a further evaluation of European Commission recommended wordings for communicating risk. , 2004, Patient education and counseling.

[38]  Lisa M. Schwartz,et al.  The value of benefit data in direct-to-consumer drug ads. , 2004, Health affairs.

[39]  Ahmed H. YoussefAgha,et al.  Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Rosalie Dominik,et al.  Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness. , 2003, Obstetrics and gynecology.

[41]  J. Ward,et al.  Original Paper: Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial , 2003 .

[42]  A. Laupacis,et al.  The effect of qualitative vs. quantitative presentation of probability estimates on patient decision‐making: a randomized trial , 2002, Health expectations : an international journal of public participation in health care and health policy.

[43]  Katrina Armstrong,et al.  Effect of Framing as Gain versus Loss on Understanding and Hypothetical Treatment Choices: Survival and Mortality Curves , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[44]  M Bobrow,et al.  Numbers or words? A randomized controlled trial of presenting screen negative results to pregnant women , 2000, Prenatal diagnosis.

[45]  K. Teigen,et al.  The Directionality of Verbal Probability Expressions: Effects on Decisions, Predictions, and Probabilistic Reasoning. , 1999, Organizational behavior and human decision processes.

[46]  D H Hickam,et al.  How Patients' Preferences for Risk Information Influence Treatment Choice in a Case of High Risk and High Therapeutic Uncertainty , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[47]  Glyn Elwyn,et al.  General practice registrar responses to the use of different risk communication tools in simulated consultations: a focus group study , 1999, BMJ.

[48]  N A Connelly,et al.  Evaluating Risk Communication: Examining Target Audience Perceptions About Four Presentation Formats for Fish Consumption Health Advisory Information , 1998, Risk analysis : an official publication of the Society for Risk Analysis.

[49]  P R Dear,et al.  How do parents of babies interpret qualitative expressions of probability? , 1990, Archives of disease in childhood.

[50]  D. Halpern,et al.  Using statistical risk information to assess oral contraceptive safety , 1989 .

[51]  Wibecke Brun,et al.  Verbal probabilities: Ambiguous, context-dependent, or both? , 1988 .

[52]  P. Gardner,et al.  Communicating the Risk of Side Effects to Patients , 2009, Drug safety.

[53]  MPH Michael P. Pignone MD,et al.  A randomized comparison of patients’ understanding of number needed to treat and other common risk reduction formats , 2007, Journal of General Internal Medicine.

[54]  J. Ward,et al.  Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. , 2003, Journal of medical screening.

[55]  Alan Lyles,et al.  Direct marketing of pharmaceuticals to consumers. , 2002, Annual review of public health.

[56]  Michael Pignone,et al.  Numeracy and the medical student's ability to interpret data. , 2002, Effective clinical practice : ECP.